Skip to content

A Study of the Effect of Blood Glucose Management Using Diet and Continuous Glucose Monitoring on Prevention of Perinatal Complications in Patients with Gestational Diabetes Mellitus

A Study of the Effect of Blood Glucose Management Using Diet and Continuous Glucose Monitoring on Prevention of Perinatal Complications in Patients with Gestational Diabetes Mellitus - SMU-GDM01 study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031240590
Enrollment
36
Registered
2024-12-27
Start date
2024-12-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

(1) Comparative study on blood glucose level transition by foods for split meals Step 1 (7 days in total) Study foods A, B, C, D and conventional diet will be consumed in the early morning at fasting

Sponsors

Yasuda Shigemitsu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Outpatients who meet all of the following criteria can be enrolled in this study; 1. patients diagnosed with gestational diabetes mellitus at the Department of Endocrinology and Diabetes, Saitama Medical University Hospital, who are treated with diet and exercise therapy alone or with insulin preparations in addition to diet and exercise therapy 2. patients who are 18 years of age or older at giving their consent 3. patients with a pregnancy between 5 and 28 weeks at giving their consent 4. Patients with HbA1c of 6.4% or less at giving their consent 5. If the patients use insulin, patients who have not changed their insulin dose from 4 weeks prior to the date of consent until the date of consent 6. Patients who give ther consent by written form to participate in this study

Exclusion criteria

Exclusion criteria: Patients who fall into any of the following criteria at giving their consent are excluded from participating in this study; 1. Patients obviously diagnosed with diabetes mellitus during pregnancy or diabetic complicated pregnancy 2. Patients using anti-diabetic agents other than insulin 3. Patients obviously diagnosed with pregnancy-induced hypertension 4. Patients using medical agents known to induce abnormal glucose metabolism (psychotropic drugs, corticosteroids, etc.) or suffering from diseases causing secondary diabetes (Cushing's syndrome, primary aldosteronism, endocrine disorders such as hyperthyroidism, liver cirrhosis, chronic pancreatitis, etc.) 5. Patients with possible food allergies to any of the components (e.g., flour, egg, milk, soy, fish meat, etc.) of the study food. 6. Patients with other conditions that the investigator thinks unsuitable for participating in this study

Design outcomes

Primary

MeasureTime frame
Although this study will compare the transition of glucose levels obtained by CGM in the three times daily diet and the six times daily split-meal diet, there are no papers in which the Time in range (TIR), one of the major indexes of CGM and the primary endpoint in this study, was calculated in the six times daily split-meal diet. Therefore, the primary endpoint will be the mean value and 95% confidence interval of the TIR calculated from the transition of glucose levels measured by CGM over 24 hours in the six times daily split-meal diet.

Secondary

MeasureTime frame
Step 1: Effect of snacking foods on blood glucose levels: - The maximum change in blood glucose level from baseline (30 minutes before consumption) to within 2 hours after consumption of each food, measured by CGM. - Time of the maximum change in blood glucose levels from baseline (30 minutes before consumption) to within 2 hours after consumption of each food, measured by CGM. - AUC of blood glucose levels from baseline (30 minutes before consumption) to within 2 hours after consumption of each food, measured by CGM. - preference questionnaire Step 2: Efficacy of split-meals: - Trends in glucose levels over 24 hours as measured by CGM during the study period comparing the normal diet (3 meals per day) and the six times split meals diet - % time in range (TIR), which is the time in the range of 72 to 140 mg/dL, - % time below range (TBR), which is the time of 140 mg/dL - mean glucose value - fluctuation of glucose level (coefficient of variation / CV) - the maximum glucose level in 24 hours during the comparison study - the minimum glucose level in 24 hours during the comparison study

Contacts

Public ContactShigemitsu Yasuda

Saitama Medical University Hospital

syasuda@saitama-med.ac.jp+81-49-276-1204

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026